Deal consolidates firms’ technology in molecular diagnostics. Qiagen and Digene entered into a definitive agreement to combine the two companies to create market and technology leadership in molecular ...
-- Digene shareholders who tendered Digene shares in the exchange offer and elected to receive cash consideration or did not make an election in respect of those shares, representing approximately ...
LONDON (MarketWatch) -- Digene Corp. said that it has signed a settlement and license deal with Georgetown University over patent litigation. Digene will record a pretax charge of $7.5 million in ...
GAITHERSBURG, Md., Jan. 11, 2008 -- QIAGEN Gaithersburg Inc. (formerly Digene Corporation), a wholly owned subsidiary of QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) today announced that it was granted ...
What: Daryl Faulkner, Chief Executive Officer of Digene Corporation (DIGE), will preside over the opening bell in honor of "Cervical Cancer Screening Month." Where: NASDAQ MarketSite - 4 Times Square ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results